13th Antibody Industrial Symposium (AIS) 2025

Meet Novalix at the 13th edition of Antibody Industrial Symposium (AIS 2025), an internationally renowned event co-organized by LabEx MAbImprove and MabDesign. Dedicated to the future of therapeutic antibodies, recombinant proteins, and biomedicines, AIS 2025 promises an exceptional program covering the full spectrum from early research to clinical applications.

This prestigious gathering brings together leading experts, innovators, and decision-makers from across the globe to exchange ideas, showcase breakthrough research, and discuss the major trends shaping the biotherapy landscape. Attendees will benefit from a rich agenda featuring keynote lectures, project pitch sessions, and presentations from top pharmaceutical players.

This year’s symposium, structured around 11 focused sessions, will spotlight key topics such as multispecific and bispecific antibodies, immunocytokines, next-generation anti-PD-1 therapies, AI-driven design tools, biomarker assays for ADC selection, and the optimization of Fc domains, among others. Regulatory considerations, safety, and intellectual property challenges will also be at the heart of discussions.

AIS 2025 also offers unparalleled networking opportunities, fostering collaboration and enabling companies to present their latest technologies and innovations.

Event location:
Palais des Congrès de Tours, France

If you are also attending AIS 2025, set a meeting and catch up. We look forward to meeting you there and contributing to reshaping the future of therapeutic biomedicines!